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EndocytosisDietary iron absorption regulation is one of the key steps for the maintenance of the body iron homeostasis.
HFE gene expression undergoes a complex post-transcriptional alternative splicing mechanism through which
two alternative transcripts are originated and translated to a soluble HFE protein isoform (sHFE). The ﬁrst pur-
pose of this study was to determine if sHFE transcript levels respond to different iron conditions in duodenal
and macrophage cell models. In addition, we aimed to determine the functional effect of the sHFE protein on
the expression of ironmetabolism-related genes in a duodenal cellmodel aswell as, in vivo, in duodenum biopsy
samples.
Levels of sHFE transcripts were measured in HuTu-80, Caco-2, HT-29 and activated THP1 cells, after holo-Tf
stimulus, and in total RNA from duodenum biopsies of functional dyspepsia patients. Also, the expression of
several iron metabolism-related genes was determined after endogenous and exogenous overexpression of
sHFE protein in a duodenal cell model. sHFE endocytosis mechanism was studied using endocytosis inhibitors.
Our results showed that sHFE transcript expression was up-regulated after holo-Tf stimuli. Hephaestin and duo-
denal cytochrome b expressionswere down-regulated by both endogenous HFE and sHFE proteins in a duodenal
cell model. Exogenous sHFE was able to down-regulate hephaestin mRNA levels by a clathrin-independent,
dynamin-mediated, and RhoA-regulated endocytosis mechanism. Moreover, HEPH levels negatively correlated
with sHFE levels in the duodenum of functional dyspepsia patients. Thus, sHFE seems to be an important iron
metabolism regulator playing a role in the control of dietary iron absorption in the duodenum.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
Every day, the human body needs to absorb approximately 1 mg of
iron from the diet in order to compensate unspeciﬁc losses that may
occur [1]. As there are no active mechanisms to excrete iron, and since
both iron deﬁciency and overload can be harmful [1], the human body
has developed ﬁne-tuned iron homeostasis regulation mechanisms.
These encompass iron absorption by duodenum enterocytes, storage
in liver hepatocytes and recycling by macrophages. Regarding absorp-
tion, dietary iron is presented as heme or as Fe3+. The latter needs to
be reduced by the duodenal cytochrome b reductase (Cybrd1) at the
enterocyte apical membrane, in order to be transported into the cell
via divalent-metal transporter 1 (Dmt1) [2,3]. Once in the cell, Fe2+ is
directed to the basolateral membrane where it is converted in Fe3+ byd transferrin; Cybrd1, duodenal
fR, transferrin receptor; TfSat,
A, phorbol 12-myristate 13-
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austino).hephaestin (Heph, a membrane associated ferrous oxidase) [4,5],
which also mediates iron efﬂux towards circulatory transferrin most
likely in cooperation with the basolateral iron transporter, ferroportin
(Fpn1).
The liver is so far the main organ considered to be involved in iron
homeostasis regulation. As iron levels increase, there is concomitant en-
hancing in the synthesis of the hormone hepcidin (coded by the HAMP
gene) by hepatocytes [6]. When released into the circulation, hepcidin
acts by binding to the membrane Fpn1, triggering its internalization
and degradation. Therefore, it prevents the release of iron from cells, in-
cluding the dietary iron absorbed by the enterocytes [7]. The molecular
mechanisms responsible for HAMP gene expression are mediated
through membrane-surface proteins such as HFE, transferrin recep-
tors-1 and -2 (TfR1, TfR2), hemojuvelin (Hjv) and bone morphogenetic
protein receptors (BmpRs) [8,9].
HFE is a major histocompatibility complex class I-like protein which
gene is commonlymutated in hereditary hemochromatosis (HH; OMIM
235200), an autosomal recessive disorder characterized by excessive in-
testinal iron absorption and deposition in several organs [10]. The ex-
pression of HFE undergoes a complex post-transcriptional regulation
that involves alternative polyadenylation and splicing mechanisms. So
far, there were identiﬁed four different polyadenylation signals and
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[11–13]. The expression of these variants seems to be ubiquitous and
their functional characterization is not yet complete. The full-length
HFE protein, resulting from the complete inclusion of the ﬁrst six
exons of HFE, is known to suffer intracellular processing through
which is associated with the chaperone β2-microglobulin (β2M) [14].
It is then transported to the cell surface, where it interacts with TfR1
in the presence of normal circulatory holo-transferrin (holo-Tf) levels
[15,16]. The main function of HFE is assumed as being the regulation
of HAMP expression in the liver. It has been hypothesized that when
holo-Tf levels increase, HFE dissociates fromTfR1 and becomes available
to interact with TfR2 and Hjv, triggering signaling pathways that pro-
mote HAMP gene expression by the hepatocytes [8,17–19]. However,
this was recently challenged with results showing that HFE and TfR2
do not interact and that the HFE-mediated HAMP expression activation
does not require TfR2 [20,21]. On the other hand, it was also proposed
that full-length HFE may act directly in enterocytes, regulating iron ab-
sorption. It was shown that HFE overexpression in colon colorectal ade-
nocarcinoma HT-29 cell line inhibits iron efﬂux from cells possibly by
the down-regulation of HEPH expression [22]. Also, the expression of
CYBRD1, as well as the integrity of duodenal epithelium, was shown to
be altered in HFE knockout mice [23–25].
Amongst the HFE mRNA alternative splicing variants, two were
shown to give rise to a truncated soluble HFE protein isoform (sHFE).
These alternative transcripts result from the total inclusion ofHFE intron
4 or the inclusion of the ﬁrst 66 base-pairs of intron 4 and, in both cases,
an in frame premature termination codon is formed, six nucleotides
from the exon 4/intron 4 boundary [12]. The sHFE protein preserves
an intactα3 domain but lacks the transmembrane domain and the cyto-
plasmic tail. Consequently, it maintains the ability to associatewithβ2M
but not with TfR1 and it has been shown to be secreted to the extracel-
lular environment in several cell types [12]. However, the function of
sHFE is still unknown.
In this study, we investigated if iron affects the expression levels of
sHFE transcripts in duodenal and macrophage cell line models. We
have also determined the effect of the presence of both the endogenous
and exogenous sHFE isoform on the transcriptional regulation of several
ironmetabolism-related genes in a duodenal cell linemodel. The results
obtained were validated by in vivo studies performed in duodenum
biopsies.
2. Methods
2.1. Plasmid constructs
The cloning of both HFE and sHFE cDNAs into the pcDNA3 vector
(Clontech, Mountain View, CA, USA) took advantage of the constructs
described inMartins andSilva et al., 2011 [12]. These constructs, contain-
ing the totalHFE or the sHFE cDNAs, were used to amplify the entire cod-
ing sequences with the forward primer 5′-ttttggtaccatgggcccgcgagcc-3′
containing the KpnI linker and the reverse primers 5′-ttttgatatctcaga
tcttatcgtcgtcatccttgtaatccatctcacgttcagctaagacgtagtgccc-3′ or 5′-ttttga
tatctcagatcttatcgtcgtcatccttgtaatccatcataccccagatcacaatgagggg-3′ (for
total HFE and sHFE, respectively) containing the EcoRV linker next to
the stop codons and Flag epitope sequence (stop codon was modiﬁed
in order to allow fusion to Flag open reading frame). Both pcDNA3
empty vector and PCR products were digested with the KpnI and EcoRV
endonucleases and ligation was performed in order to obtain the
pcDNA + HFE-Flag and pcDNA + sHFE-Flag constructs. The sequences
of constructs were conﬁrmed by automated Sanger sequencing. The
pGFP +RhoA_N19 construct was kindly given by Dr. Peter Jordan [26].
2.2. Cell culture and transfection
HuTu-80 cells (human duodenal enterocyte cell line) and HEK293
cells (used for protein production) (DSMZ, Germany) were maintainedin DMEMGlutaMAX™medium (Invitrogen, Carlsbad, CA, USA) supple-
mented with 10% (v/v) fetal bovine serum (FBS), while THP-1 cells
(human monocyte-derived cell line), Caco-2 and HT-29 cells
(human epithelial colorectal adenocarcinoma cells) (DSMZ,
Germany) were maintained in RPMI 1640 medium (Invitrogen,
Carlsbad, CA, USA) supplemented with 10% (v/v) FBS, in a 37 °C/5%
CO2 incubator.
For iron overload experiments, HuTu-80, THP-1 and HT-29 cells
were seeded in 35 mm plates at a conﬂuence of 1 × 106 cells per well,
while Caco-2 cells were seeded at a conﬂuence of 5 × 105 cells
per well. THP-1 cells were seeded in the presence of 5 ng/mL phorbol
12-myristate 13-acetate (PMA; Sigma, St. Louis, MO, USA) for differen-
tiation. Twenty-four hours after seeding (or 48 h for THP-1 and HT-29
cells), the media were replaced with fresh media containing 20 μM
holo-Tf or 20 μM apo-Tf (Sigma, St. Louis, MO, USA) (or the same
volume of vehicle solution, H2O). Cells were harvested 12 h after
stimulus was given.
For transient transfection experiments, cells were seeded in 35 mm
plates at a conﬂuence of 1 × 106 cells per well (or 5 × 105 cells for
Caco-2). Twenty-four hours after seeding, 2 μg of the pcDNA + HFE
constructs were used together with Lipofectamine 2000 Transfection
Reagent (Invitrogen, Carlsbad, CA, USA) following the
manufacturer's instructions. Two hours after transfection medium
was replaced with fresh medium containing 20 μM holo-Tf (or the
same volume of vehicle solution, H2O). Twenty-four hours later,
cell culture supernatant and cells were collected for immunoprecip-
itation and RNA extraction.
The exogenous sHFE experiments were performed by producing
sHFE protein in HEK293 cells. Brieﬂy, HEK293 cells were seeded and
transfected with 2 μg of the pcDNA + HFE constructs. Two hours later
the medium was replaced and after 48 h of culture, the supernatant
was collected and centrifuged for clearing from dead cells and debris.
The cleared supernatant was then added to previously seeded HuTu-80
cells in a ratio of 3:1 (supernatant: fresh medium). Endocytosis inhibi-
tion was carried on HuTu-80 cells by replacing the medium with fresh
medium containing 40 μM dynasore (Sigma, St. Louis, MO, USA) or
10 μg/mL Chlorpromazine (CPZ; Sigma, St. Louis, MO, USA) 30 min be-
fore and when conditioned supernatant was added (or an equivalent
volume of vehicle solution, DMSO). Cells were then harvested for RNA
4 h later. For RhoA inhibition experiments HuTu-80 cells were
transfected with 2 μg of pGFP (empty-vector) or pGFP-RhoA_N19, 24 h
prior to the replacement with conditioned medium. Cells were then
harvested for RNA and protein 4 h later.
2.3. Patients' selection, peripheral blood biomarkers and isolation of duode-
num biopsies
A group of 6 individuals referred for endoscopy due to dyspepsia
symptoms at the Departamento de Gastroenterologia e de Hepatologia,
Hospital Santa Maria, Lisbon, was enrolled in this study. Besides
dyspepsia, these patients presented no other pathological conditions.
The ethical committee of the Hospital Santa Maria approved the study,
and all patients signed an informed consent.
Patient's peripheral blood samples were obtained by venipuncture.
Serum was isolated and used for the measurement of iron metabolism
biomarkers by the standard protocols (Table 1). Duodenum biopsies
were collected and immediately stored in RNA later (Quiagen, CA,
USA) at−80 °C.
2.4. RNA extraction and real time-qPCR
Total RNA extraction from cultured cells was carried out by using a
NucleoSpin® RNA II kit (Macherey Nagel, Düren, Germany) according
to the manufacturer's instructions. RNA extraction from dyspepsia
patients' duodenum biopsies was performed by a standard Trizol
Table 1
Characterization of iron status of the dyspepsia patients analyzed in the current work.
Patient Gender Age Serum iron
(μg/dL)
Transferrin
(μg/dL)
TfSat
(%)
Serum ferritin
(μg/L)
I F 49 80 270 29.6 41
II F 21 70 359 19.4 201
III F 45 135 456 29.6 291
IV M 52 91 327 27.8 825
V M 34 145 400 36.3 50
VI M 51 120 282 42.6 300
M: male; F: female; and TfSat: transferrin saturation.
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treated with DNase I (Roche, Mannheim, Germany).
First strand cDNA synthesis was performed by using 2–5 μg of total
RNA together with an equivalent mixture of random primers and
oligo(dT)12–18 and the SuperScript II Reverse Transcriptase (Invitrogen,
Carlsbad, CA, USA), according to the manufacturer's instructions. To
discard DNA contamination in the RNA samples a control PCR was
performed for the ABL gene.
Quantiﬁcation of ironmetabolism-related gene expression was con-
ducted using real-time qPCR performed on an ABI Prism 7000 Sequence
Detection System. Primers were designed to amplify speciﬁc amplicons
of the total HFE, sHFE, TFR1, HAMP, IL1-β, SLC11A2, SLC40A1, CYBRD1,
HEPH and HPRT1 transcripts (Table S1). Each cDNA sample was diluted
5-fold and then 5 μL of dilutions added to 5 pmol of each primer and
SYBR Green Master Mix (Applied Biosystems, Warrington, UK). The
cycling parameters were: 10 min at 95 °C, followed by 40 cycles of 15
s at 95 °C and 1min at 60 °C. Quantiﬁcation of gene expressionwas per-
formed by the 2^−ΔCtmethod usingHPRT1 as the normaliser gene. Each
samplewas quantiﬁed in triplicate and primer ampliﬁcation efﬁciencies
were calculated and validated with the standard curves obtained
through the ampliﬁcation of cDNA serial dilutions.2.5. Immunoprecipitation
Twenty-four hours after transfection, both cell media (b2 mL) and
platted cells were harvested. Cell media were centrifuged and the su-
pernatants collected. A total of 150 μL of lysis buffer was then added,
on ice, to this supernatant and cells [12]. The supernatant and cell ly-
sates were cleared by centrifugation and an aliquot of 20 μL transferred
to 2× Laemmli buffer. Then 8 μL ofmouse anti-FlagM2 antibody (Sigma,
St. Louis, MO, USA) was added and after one hour of incubation at 4 °C,
60 μL of G-agarose bead slurry was added overnight. The beads were
spun down, washed three times and the protein was resuspended in
2× Laemmli buffer.2.6. Western blot analysis
Proteins from cell lysates or from cell culture supernatants were
resolved in a 12% SDS-PAGE and transferred to PVDF membranes
(Bio-Rad, Hercules, CA, USA), which were blocked using a 10% (m/v)
TBST-Milk solution. Membranes were probed using rabbit anti-Flag
(Sigma, St. Louis, MO, USA) at a 1:500 dilution, rabbit anti-GFP
(Abcam, Cambridge, UK) at a 1:5000 dilution, rabbit anti-β2M
(Abcam, Cambridge, UK) at a 1:500 dilution or mouse anti-TfR1
(Invitrogen, Carlsbad, CA, USA) at a 1:500 dilution. For pre-IP lysates,
a mouse anti-HSP90β antibody (Invitrogen, Carlsbad, CA, USA) was
used as a loading control at a 1:100 dilution. Detection was carried
out using secondary peroxidase-conjugated anti-mouse IgG (Bio-Rad,
Hercules, CA, USA) at a 1:4000 dilution or anti-rabbit IgG (Bio-Rad, Her-
cules, CA, USA) at a 1:3000 dilution, followed by chemiluminescence
assays.2.7. Statistical analysis
Data are presented as means ± standard deviations obtained from
at least three independent experiments. Groups were compared with
Student's t test. Correlations were calculated with the PASW Statistics
20.0® software (SPSS Inc.). Two-sided p-values of b0.05 indicated
statistical signiﬁcance, while one-sided p-values are presented for the
control experiments.
3. Results
3.1. Holo-transferrin regulates the expression of sHFE transcripts in
duodenal and macrophage cell models
In order to determinewhether iron modulates the expression of the
alternative HFE transcripts responsible for the sHFE isoform production,
we stimulated HuTu-80, Caco-2, HT-29 and activated THP-1 cells with
20 μM holo-Tf for 12 h. After mRNA extraction, quantiﬁcation of total
HFE, sHFE and TFR1 transcripts was performed (Fig. 1). We observed
that, in HuTu-80, Caco-2, HT-29 and activated THP-1 cells, TFR1 expres-
sion was down-regulated by holo-Tf (0.65 ± 0.12, p= 0.0018; 0.57 ±
0.09, p = 0.0002; 0.61 ± 0.16, p = 0.0142 and 0.67 ± 0.08, p =
0.0054, respectively). No signiﬁcant differences were found in total
HFE expression (0.88 ± 0.10, p = 0.1330; 1.095 ± 0.21, p = 0.4548;
1.042 ± 0.22, p = 0.7447 and 0.95 ± 0.24, p = 0.7263 for HuTu-80,
Caco-2, HT-20 and activated THP-1 cells, respectively). On the other
hand, the expression of the sHFE transcripts increased with holo-Tf in
HuTu-80, Caco-2 and activated THP-1 cells (1.37 ± 0.16, p = 0.0269;
1.26 ± 0.10, p = 0.0241 and 1.54 ± 0.27, p = 0.0280, respectively)
(Fig. 1A, B and D), while no differences were found in the HT-29 cells
(1.05 ± 0.18, p = 0.6714) (Fig. 1C). Also, the mRNA levels of TFR1,
total HFE and sHFE do not vary with apo-Tf stimuli in Hutu-80 and
Caco-2 cells (Fig. S1). The control of THP-1 activation by PMA was
performed by the quantiﬁcation of IL1βmRNA levels (Fig. S2).
3.2. sHFE protein isoform overexpression down-regulates CYBRD1 and
HEPH transcript expressions in Hutu-80 cells
Since the previous experiments revealed increased sHFE transcript
levels in response to holo-Tf stimulus, we investigated the effect of the
overexpression of both the full-length HFE and the sHFE proteins in
Hutu-80, Caco-2 and HT-29 cells in the expression of several iron me-
tabolism genes (Figs. 2 and S3). The immunoblot results conﬁrmed
the transient overexpression of both full-length HFE- and sHFE-Flag fu-
sions independently of holo-Tf in HuTu-80 cells (Fig. 2A). The immuno-
precipitation performed on cell lysates showed that the HFE full-length
protein was associated with β2M and TfR1 in normal conditions
(Fig. 2B). However, when holo-Tf was added, we could no longer
observe the association with TfR1 (Fig. 2B, left panels). On the other
hand, sHFE isoform was found associated only with β2M. Also, as
expected, the immunoprecipitation performed on the cell culture
supernatant showed that the full-length HFE was not present in the
extracellular environment. Conversely, we have detected sHFE protein
associatedwithβ2M, independently of iron status (Fig. 2B, right panels).
Regarding the effect of the overexpression of both HFE and sHFE
proteins on iron metabolism gene expression in HuTu-80 cells, we did
not detect signiﬁcant differences on the levels of TFR1, SLC11A2 and
SLC40A1 (Fig. 2C–E). However we did observe a decrease of CYBRD1
and HEPH gene expression (Fig. 2F and G). Particularly, the expression
of CYBRD1 decreased approximately 20% with the overexpression of
both the full-length HFE and sHFE proteins (0.79 ± 0.07, p = 0.0418
and 0.77 ± 0.04, p = 0.0190, respectively) (Fig. 2F). The observed
differences were shown to be independent of holo-Tf stimuli. On the
other hand, the overexpression of full-length HFE led to a 16% decrease
of HEPH expression (0.84 ± 0.04, p= 0.0302). This decrease was even
higher when holo-Tf was added (0.53 ± 0.12, p = 0.0083) (Fig. 2G).
Fig. 1. Effect of holo-Tf on the expression of sHFE transcripts. (A) HuTu-80, (B) Caco-2, (C) HT-29 and (D) PMA-activated THP-1 cells were stimulated with medium containing
20 μM holo-Tf for 12 h and the expression of TFR1, totalHFE and sHFEwas analyzed by RT-qPCR. Mock refers to the control cells without the stimuli but with the same amount of vehicle
solution (H2O). Values were obtained by normalizing ﬁrst the expression to HPRT1 and then to the mock control. Bars represent the standard deviations from at least three independent
experiments; *p b 0.05; **p b 0.001.
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HEPH's expression (0.69 ± 0.14, p= 0.0235) (Fig. 2G). Under holo-Tf
stimulus the expression decreased to approximately half of the normal
expression (0.47 ± 0.04, p= 0.0001) (Fig. 2G).Fig. 2. Effect of sHFE protein overexpression on the levels of expression of iron metabolism-re
(mock), pcDNA + HFE-Flag and pcDNA + sHFE-Flag constructs under regular and iron overl
cells were harvested for RNA and protein and culture supernatant collected. Protein lysates a
Flag monoclonal antibody and G-agarose beads. Immunoblot detection was performed on (A)
culture supernatants (right panels). Blots were incubated with anti-Flag, -TfR1, -β2M and -HS
(C) TFR1 (D) SLC11A2 (E) SLC40A1 (F) CYBRD1 and (G) HEPH by RT-qPCR. Values were obtai
holo-Tf. Bars represent the standard deviations from at least three independent experiments; *This result was, however, different when Caco-2 and HT-29
cells were transfected with the same constructs, as no signiﬁ-
cant differences in CYBRD1 and HEPH expressions were found
(Fig. S3).lated genes in HuTu-80 cells. HuTu-80 cells were transfected with pcDNA3 empty vector
oad conditions (−holo-Tf and +holo-Tf, 20 μM, respectively). Twenty-four hours later,
nd cell culture supernatant were subjected to immunoprecipitation using a mouse anti-
crude cell lysates and (B) immunoprecipitation products from cells (left panels) and cell
P90β antibodies for protein detection. RNAs were used to assess the expression levels of
ned by normalizing ﬁrst the expression to HPRT1 and then to the mock control without
p b 0.05; **p b 0.001.
2302 B. Silva et al. / Biochimica et Biophysica Acta 1842 (2014) 2298–23053.3. HEPH transcript expression is down-regulated by exogenous sHFE
protein isoform through an endocytosis dependent mechanism
The expression of transcripts that can give rise to the sHFE protein
was previously described as ubiquitous [12]. Here we have found that
the endogenous overexpression of this protein in HuTu-80 cells induces
a decrease in the expression of CYBRD1 andHEPH transcripts. Therefore,
we aimed to determine if the presence of the exogenous sHFE protein
could also induce the same effect on the expression of these genes in
the same duodenal cell model. In order to achieve this, we transfected
HEK293 cells with pcDNA+HFE and+ sHFE constructs. Then, the con-
ditioned medium was used to stimulate HuTu-80 cells and the expres-
sion of CYBRD1 and HEPH was measured. We observed that no effect
was found in the expression of CYBRD1 four hours after the stimulus
(Fig. 3A). This expression remained unchanged evenwhen the exposure
to conditioned media was extended up to 24 h (data not shown). Oth-
erwise, we found that the exposure of these cells to sHFE conditioned
medium induced the decrease of HEPH expression (0.73 ± 0.19, p =
0.0309) (Fig. 3B). However, when we inhibited dynamin-dependent
endocytosis with dynasore, we no longer observed the same effect
(1.04 ± 0.13, p= 0.5917) (Fig. 3B). The efﬁcacy of endocytosis inhibi-
tionwas tested by the effect of holo-Tf on TFR1 expression. As expected,
the observed decrease of TFR1 expressionwas signiﬁcantly repressed in
the presence of dynasore (p = 0.0071) (Fig. 3C), therefore validating
dynamin-dependent endocytosis inhibition. The inhibitory effect of ex-
ogenous sHFE in the expression of HEPH was not observed in either
Caco-2 or HT-29 cells (Fig. S4).
Since the dynamin-dependent endocytosis mechanism may be,
or not, clathrin-dependent, we further analyzed the effect of CPZ
(clathrin-dependent endocytosis inhibitor) in HEPH down-regulation
by exogenous sHFE in HuTu-80 cells. We observed that, the treatment
of HuTu-80 cells with CPZ did not prevent the down-regulation ofFig. 3. Effect of exogenous sHFE stimulus on the expression of ironmetabolism-related genes inHu
Flag and pcDNA+sHFE-Flag constructs. Forty-eight hours post-transfection cell culture supernata
was inhibitedwith dynasore 40 μM(dyn) or chlorpromazine 10 μg/mL (CPZ). Four hours later, cell
by RT-qPCR. (C, F) HuTu-80 cells were stimulatedwithmedium containing both holo-Tf 20 μMan
sured as the inhibition of TFR1 decrease by holo-Tf. Values were obtained by normalizing ﬁrst the
deviations from at least three independent experiments; *p b 0.05; **p b 0.001.HEPH expression by exogenous sHFE (0.57 ± 0.21, p = 0.0271)
(Fig. 3E), while it partially prevented the TFR1 down-regulation effect
by holo-Tf (1.01 ± 018, p= 0.2259) (Fig. 3F).
To investigate whether RhoA-regulated endocytosis is the mecha-
nism responsible for sHFE endocytosis, we transfected HuTu-80
cells with a dominant negative form of RhoA GTPase (RhoA_N19)
prior to adding exogenous sHFE (Fig. 4). We found that the overexpres-
sion of RhoA_N19 inhibited HEPH down-regulation by exogenous sHFE
(p= 0.0322) (Fig. 4B).
3.4. HEPH and sHFE expression levels are correlated in the human
duodenum
Since we found that the sHFE transcript expression levels increased
with iron stimulus in duodenal and macrophage cell lines, we aimed
to determine if, in vivo, there is a correlation between individual iron
status, evaluated by the peripheral blood iron metabolism biomarkers
(Table 1), and sHFE transcript expression in the duodenum (Fig. 5).
For this, we measured the mRNA levels of sHFE and HEPH in total
RNAs extracted from dyspepsia patients' duodenum biopsies.
We did not observe signiﬁcant correlations between duodenal sHFE
expression and peripheral biomarker levels of iron status— serum iron,
transferrin saturation (TfSat) and serum ferritin (Fig. 5A–C). Neverthe-
less, we observed a signiﬁcant negative correlation between sHFE and
HEPH expressions in the human duodenum (p= 0.023) (Fig. 5D).
4. Discussion
In order to access circulation, dietary iron has to surpass the barriers
created at both the apical and basolateral membranes of the enterocyte.
The ﬁrst step consists in the luminal reduction of Fe3+ by Cybrd1 and
transport into the enterocyte by Dmt1 [2,3]. Secondly, iron crosses theTu-80 cells. HEK293 cellswere transfectedwith pcDNAempty vector (mock), pcDNA+HFE-
ntswere collected and then used to stimulate previously culturedHuTu-80 cells. Endocytosis
swere harvested for RNAand the expression of (A, D)CYBRD1 and (B, E)HEPHwas evaluated
d dynasore 40 μMor chlorpromazine 10 μg/mL, to control the inhibition of endocytosismea-
target gene expression to HPRT1 and then to the mock control. Bars represent the standard
Fig. 4. Effect of RhoA-mediated endocytosis inhibition inHEPH downregulation by exoge-
nous sHFE in HuTu-80 cells. HuTu-80 cells were transfected with pGFP empty-vector
(GFP) or with pGFP + RhoA_N19, 24 h prior to medium replacement with sHFE
conditioned medium. Cells were then harvested after 4 h for protein and RNA.
(A) Immunoblot detection was performed on protein lysates and blots were incubated
with anti-GFP and -HSP90β antibodies for protein detection. (B) HEPH expression was
evaluated by RT-qPCR. Values were obtained by normalizing ﬁrst the target gene expres-
sion toHPRT1 and then to themock control. Bars represent the standarddeviations fromat
least three independent experiments; *p b 0.05; **p b 0.001.
Fig. 5. Correlation of duodenal sHFE expression levels with peripheral blood iron metabolism
were used for RNA extraction and the expression levels of sHFE and HEPH transcripts assesse
sHFE and (A) serum iron, (B) Tf sat, (C) serum ferritin and (D) HEPH expression. Trend lines ar
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Heph, the enterocyte membrane-bound ferrous oxidase [4]. Whenever
iron fails to cross this second barrier it remains inside the enterocytes
and is eliminated by cell desquamation. Also, it is known that when
body iron levels rise, the expression of hepcidin is stimulated in the
liver, secreted into the circulation and, consequently, Fpn1 is internal-
ized and degraded, therefore preventing iron absorption [7]. One of
the mechanisms underlying HAMP expression regulation in the liver in
response to iron is co-dependent on the presence of HFE protein in
the hepatocyte membrane. Regardless, HFE has a ubiquitous expression
in human cells and it may also act directly in the enterocyte preventing
iron absorption [22]. In addition, HFE gene expression undergoes com-
plex post-transcriptional processing and, to date, several alternative
splicing transcripts have been described. Of these, two, originated
from the total or partial intron 4 inclusions, give rise to the soluble
form of HFE protein [12].
Previous studies have shown that HFEmRNA levels do not vary as a
consequence of iron overload [27,28]. Accordingly, in this study we ob-
served that total HFE mRNA levels remain unchanged upon holo-Tf
stimulus in duodenal and activated-monocyte cell lines. However, we
found that the level of the transcripts which originate the sHFE protein
isoform increases with holo-Tf but not with apo-Tf stimulus. Therefore,
we hypothesize that holo-Tf may somehow up-regulate the expression
of HFE intron 4 inclusion variants while down-regulating other alterna-
tive splicing variants and therefore maintaining the levels of total HFE
expression. Actually, it has been reported that iron modulates aberrant
splicing of ferrochelatase by acting as co-factor for the lysyl-
hydroxylation of the splicing factor U2AF, important for the binding to
the polypyrimidine tract upstream from the 3′ splice site [29]. Also,
the expression of SFRS5 gene, coding for the serine–arginine-rich phos-
phoprotein 40 (SRp40), an important regulator of pre-mRNA splicing,
was found up-regulated in the duodenum of mice fed with an iron-
supplemented diet [30]. Indeed, in the HFE intron 4 sequence there
are six motifs with afﬁnity for the SRp40 (data not shown) and it wasbiomarkers and duodenal HEPH expression. Duodenum biopsies from dyspepsia patients
d by RT-qPCR using HPRT1 as a normalizer gene. Correlations were established between
e presented; r represents the Pearson's correlation value.
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CD44 inclusion variants as well as with the translation of unspliced
HIV type 1 RNA [31,32]. So, we hypothesize that the increased expres-
sion of sHFE observed in the presence of holo-Tf may be due to an in-
crease in SRp40 that will mediate the HFE intron 4 inclusion.
Heph is a membrane associated ferrous oxidase that is responsible
for iron oxidation whenever it is exported by Fpn1 through the
basolateral membrane of enterocytes. It is preferentially expressed in
these cells, but it seems to be also expressed in the antrum, enteric ner-
vous system and pancreas [33]. So far, little is known about its expres-
sion regulation. It has already been reported that HEPH levels are not
affected in HH patients [34]. However, other authors observed that its
expression was down-regulated after transfecting HFE in HT-29 cells
[22]. Here, we also showed that the overexpression of HFE in HuTu-80
cells down-regulated HEPH, suggesting a role of HFE in the regulation
of HEPH expression. However, when we used HT-29 cells we were not
able to reproduce the same effect. Probably, this difference can be justi-
ﬁed by the location of the primer sets used for quantiﬁcation, which be-
sides amplifying the major variant of HEPH transcript may also amplify
other HEPH alternative transcripts.
A similar down-regulatory effect onHEPH expressionwas also found
consequently to the overexpression of the sHFEprotein. Since sHFE does
not have the transmembrane and cytoplasmic domains, we can con-
clude that these protein domains are not involved in HEPH regulation.
Also, it is known that sHFE is a circulatory protein, and that it might
be expressed by several tissues [12]. Our results proved that exogenous
sHFE is able to down-regulate HEPH through a clathrin-independent,
dynamin-mediated and RhoA-regulated endocytosis mechanism.
Endocytosis is an important cellular process responsible for the inter-
nalization of a diversity of molecules. Functionally it may work as a
mechanism for nutrient acquisition, damaged cell surface repairing or
even a mechanism mediating cell surface signaling pathways [35]. It
has been reported that Rho-A regulated endocytosis is dependent on re-
ceptors located in lipid rafts for vesicle formation. For instance,
interleukin-2 receptor has been shown to be endocytosed byRho-A reg-
ulated mechanism after binding to its ligands, promoting T cell prolifer-
ation [36]. Also, the Clostridium botulinum C2 toxin is internalized by a
similar pathway [37]. Since several cell surface molecules related to
iron-metabolism regulation are located in lipid rafts, we hypothesize
that the sHFE binds to one of those proteins, triggering a signaling
pathway responsible for HEPH expression down-regulation.
Besides Heph, ceruloplasmin (Cp) is other known ferrous oxidase
expressed in the human body. It exists both in circulation and attached
to the cell membrane of hepatocytes and of peripheral blood mononu-
clear cells [38]. In the current work we also have analyzed the effect of
exogenous sHFE in the expression of CP in activated THP-1 cells. Howev-
er, we observed no changes on its expression (data not shown). Despite
playing a role in iron oxidation and copper transport, Cp andHeph have
distinct expression patterns and regulatory mechanisms [39]. In addi-
tion, Heph is not able to oxidize adrenaline and dopamine as Cp does
[40]. So, it is not surprising that sHFE is not involved in the regulation
of Cp expression.
While SLC11A2 and CYBRD1were identiﬁed as being iron-responsive
mRNAs [41], we did not observe, in HuTu-80 cells, any signiﬁcant differ-
ences on their expression after holo-Tf stimuli. Similarly, previous re-
ports had shown that SLC11A2 and CYBRD1mRNA levels were affected
by iron deﬁciency more than by secondary iron overload [23,42,43].
We have also shown that CYBRD1 expression is down-regulated by
the transfection of both full-length HFE and sHFE in a duodenal cell
model. In agreement several studies have reported an increase of
CYBRD1 expression in HFE KOmice as well as in HH patients [23,25,43].
Finally, we found that sHFE expression levels are negatively correlat-
ed with HEPH expression levels in the duodenum of dyspepsia patients,
thus validating the results obtained in vitro. Despite no correlation
being achieved between sHFE expression levels in the duodenum and
the peripheral blood iron parameters, we cannot discard the hypothesisthat ironmay regulate sHFE expression, as the individuals here analyzed
did not have abnormal peripheral blood iron parameter values. It would
be important to perform these experiments in groups of patients
presenting different iron status proﬁles.
Taken together, our results show that holo-Tf up-regulates the ex-
pression of the sHFE. Also, we unveiled a role for the sHFE in the regula-
tion of enterocyte HEPH expression that may affect cellular iron efﬂux
and consequently dietary iron absorption. Vujic-Spasic and co-
workers have shown that the ablation of HFE in the intestine of mice
did not affect the physiological control of systemic iron homeostasis
[44], concluding that HFE would not have a role in the intestine under
steady state conditions. However, since sHFE is a putative circulatory
protein, we can hypothesize that its expression in the intestine might
not be essential as other tissues may be overexpressing this isoform,
as seen in this report with the activated-THP1. We propose that an in-
crease on transferrin saturation may drive to the increase of sHFE ex-
pression in several tissues. Then sHFE will act by down-regulating
HEPH expression and, most likely, inhibiting iron export from
enterocytes preventing the increase of body iron levels to a higher
extent.
Since the regulation of iron absorption is a key-step for the mainte-
nance of body iron levels, sHFE may be considered as a potential target
to the development of new therapeutic strategies for both iron deﬁcien-
cy and overload pathologies.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.bbadis.2014.07.017.
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